Multiple Doses of AT-1501-A201 in Adults With ALS
Public ClinicalTrials.gov record NCT04322149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Multiple Doses of AT-1501 in Adults With ALS
Study identification
- NCT ID
- NCT04322149
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Anelixis Therapeutics, LLC
- Industry
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- AT-1501 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2020
- Primary completion
- Mar 23, 2022
- Completion
- Mar 23, 2022
- Last update posted
- Jun 27, 2023
2020 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrows Neurological Institute | Phoenix | Arizona | 85013 | — |
| University of California Irvine | Orange | California | 92868 | — |
| California Pacific Medical Center | San Francisco | California | 94109 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| University of Indiana | Indianapolis | Indiana | 46202 | — |
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Johns Hopkins University Medical Center | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Hospital for Special Surgery (HSS) | New York | New York | 10021 | — |
| Providence Brain & Spine Institute | Portland | Oregon | 97213 | — |
| Texas Neurology, P.A. | Dallas | Texas | 75206 | — |
| Houston Methodist Neurological Institute | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04322149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2023 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04322149 live on ClinicalTrials.gov.